Ways & Means Unanimously Approves Drug-Pricing Transparency Bill

By Rachel Cohrs / April 9, 2019 at 5:14 PM
The House Ways & Means Committee on Tuesday (April 9) unanimously approved drug-pricing legislation that would demand price transparency from drug makers and pharmacy benefit managers. Though he voted for it, Rep. Lloyd Doggett (D-TX), who has been an outspoken advocate for lowering drug prices, criticized the measure for not going far enough. The legislation is a watered-down version of a bill introduced by Senate Finance ranking Democrat Ron Wyden (OR), which failed to gain Finance Chair Chuck Grassley’s (R-IA)...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.